LeCluyse EL. Human hepatocyte culture systems for the in vitro evaluation of
cytochrome P450 expression and regulation. Eur J Pharm Sci 2001a;13:343–368.
LeCluyse EL. Pregnane X Receptor: molecular basis for species differences in cyp3a
induction by xenobiotics. Chem Biol Interact 2001b;134:283–289.
Lu AY, Wang RW, Lin JH. Cytochrome P450in vitroreaction phenotyping: a
re evaluation of approaches used for P450 isoform identification. Drug Metab
Dispos 2003;31:345–350.
Luo G, Cunningham M, Kim S, Burn T, Lin J, Sinz M, Hamilton G, Rizzo C, Jolley S,
Gilbert D, Downey A, Mudra D, Graham R, Carroll K, Xie J, Madan A, Parkinson
A, Christ D, Selling B, LeCluyse E, Gan LS. CYP3A4 induction by drugs:
correlation between a pregnane x receptor reporter gene assay and CYP3A4
expression in human hepatocytes. Drug Metab Dispos 2002;30:795–804.
Luo G, Guenthner T, Gan LS, Humphreys WG. CYP3A4 induction by xenobiotics:
biochemistry, experimental methods and impact on drug discovery and development.
Curr Drug Metab 2004;5:483–505.
Ma B, Prueksaritanont T, Lin JH. Drug interactions with calcium channel blockers:
possible involvement of metabolite–intermediate complexation with CYP3A. Drug
Metab Dispos 2000;28:125–130.
Ma JD, Nafziger AN, Bertino JS Jr. Genetic polymorphisms of cytochrome P450
enzymes and the effect on interindividual, pharmacokinetic variability in extensive
metabolizers. J Clin Pharmacol 2004;44:447–456.
Ma X, Shah Y, Cheung C, Guo GL, Feigenbaum L, Krausz KW, Idle JR, Gonzalez FJ.
The pregnane X receptor gene-humanized mouse: a model for investigating drug–
drug interactions mediated by cytochromes P450 3A. Drug Metab Dispos
2007;35:194–200.
Mandal PK. Dioxin: a review of its environmental effects and its aryl hydrocarbon
receptor biology. J Comp Physiol [B] 2005;175:221–230.
Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell 1995;
83:841–850.
Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg
B, Kastner P, Mark M, Chambon P, Evans RM. The nuclear receptor superfamily:
the second decade. Cell 1995;83:835–839.
Margolis JM, Obach RS. Impact of nonspecific binding to microsomes and phospholipid
on the inhibition of cytochrome P4502D6: implications for relatingin vitroinhibition
data toin vivodrug interactions. Drug Metab Dispos 2003;31:606–611.
Mills JB, Rose KA, Sadagopan N, Sahi J, deMorais SM. Induction of drug metabolism
enzymes and mdr1 using a novel human hepatocyte cell line. J Pharmacol Exp Ther
2004;309:303–309.
Moore LB, Maglich JM, McKee DD, Wisely B, Willson TM, Kliewer SA, Lambert
MH, Moore JT. Pregnane x receptor (PXR), constitutive androstane receptor
(CAR), and benzoate x receptor (BXR) define three pharmacologically distinct
classes of nuclear receptors. Mol Endocrinol 2002;16:977–986.
Muck W. Clinical pharmacokinetics of cerivastatin. Clin Pharmacokinet 2000;39:99–
116.
Nagata K, Yamazoe Y. Genetic polymorphism of human cytochrome P450 involved in
drug metabolism. Drug Metab Pharmacokinet 2002;17:167–189.
REFERENCES 133